Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Jarvis

Showing results (301-310 of 465) with videos related to

Pageof 47
Sort By:
Antimicrobial Agents and Chemotherapy|June 7, 2017
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 StudySeema U Nayak, J McLeod Griffiss, Jeffrey Blumer, et al.
Nature Microbiology|November 14, 2018
Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrityAdam Z Cheng, Jaime Yockteng-Melgar, Matthew C Jarvis, et al.
The Journal of Biological Chemistry|November 15, 1996
Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-mybT C Jarvis, F E Wincott, L J Alby, et al.
Genes & Diseases|June 10, 2022
Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolismBrendan P Norman, Andrew S Davison, Juliette H Hughes, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2019
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut MicrobiotaBarbara K Lomeli, Hal Galbraith, Jared Schettler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 25, 2026
Repeated Disuse Atrophy Imprints a Molecular Memory in Skeletal Muscle: Transcriptional Resilience in Young Adults and Susceptibility in Aged MuscleDaniel C Turner, Truls Raastad, Max Ullrich, et al.
Journal of Inherited Metabolic Disease|February 22, 2020
Nitisinone causes acquired tyrosinosis in alkaptonuriaMilad Khedr, Maggie S Cooper, Andrew T Hughes, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2012
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targetsDouglas R Davies, Amy D Gelinas, Chi Zhang, et al.
Annals of the New York Academy of Sciences|August 3, 2023
Reimagining scientific conferences-a Keystone Symposia reportShannon Weiman, Jennifer Cable, Walter Greenleaf, et al.
Mbio|February 7, 2019
Polyomavirus T Antigen Induces <i>APOBEC3B</i> Expression Using an LXCXE-Dependent and TP53-Independent MechanismGabriel J Starrett, Artur A Serebrenik, Pieter A Roelofs, et al.
Pageof 47

Showing results (301-310 of 465) with videos related to

Sort By:
Pageof 47
Antimicrobial Agents and Chemotherapy|June 7, 2017
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 StudySeema U Nayak, J McLeod Griffiss, Jeffrey Blumer, et al.
Nature Microbiology|November 14, 2018
Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrityAdam Z Cheng, Jaime Yockteng-Melgar, Matthew C Jarvis, et al.
The Journal of Biological Chemistry|November 15, 1996
Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-mybT C Jarvis, F E Wincott, L J Alby, et al.
Genes & Diseases|June 10, 2022
Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolismBrendan P Norman, Andrew S Davison, Juliette H Hughes, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2019
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut MicrobiotaBarbara K Lomeli, Hal Galbraith, Jared Schettler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 25, 2026
Repeated Disuse Atrophy Imprints a Molecular Memory in Skeletal Muscle: Transcriptional Resilience in Young Adults and Susceptibility in Aged MuscleDaniel C Turner, Truls Raastad, Max Ullrich, et al.
Journal of Inherited Metabolic Disease|February 22, 2020
Nitisinone causes acquired tyrosinosis in alkaptonuriaMilad Khedr, Maggie S Cooper, Andrew T Hughes, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2012
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targetsDouglas R Davies, Amy D Gelinas, Chi Zhang, et al.
Annals of the New York Academy of Sciences|August 3, 2023
Reimagining scientific conferences-a Keystone Symposia reportShannon Weiman, Jennifer Cable, Walter Greenleaf, et al.
Mbio|February 7, 2019
Polyomavirus T Antigen Induces <i>APOBEC3B</i> Expression Using an LXCXE-Dependent and TP53-Independent MechanismGabriel J Starrett, Artur A Serebrenik, Pieter A Roelofs, et al.
Pageof 47